Cited by 24Neonatal Health and BiochemistryPediatric Hepatobiliary Diseases and TreatmentsMetabolism and Genetic Disorders

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Early Neonatal Bilirubin, Hematocrit, and Glucose-6-Phosphate Dehydrogenase Status

Abstract

OBJECTIVE: To document the patterns of bilirubin and hematocrit values among glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD-normal Nigerian neonates in the first week of life, in the absence of exposure to known icterogenic agents. METHODS: The G6PD status of consecutive term and near-term neonates was determined, and their bilirubin levels and hematocrits were monitored during the first week of life. Infants were stratified into G6PD deficient, intermediate, and normal on the basis of the modified Beutler’s fluorescent spot test. Means of total serum bilirubin (TSB) and hematocrits of the 3 groups of infants were compared. RESULTS: The 644 neonates studied comprised 353 (54.8%) boys and 291 (45.2%) girls and 540 (83.9%) term and 104 (16.1%) near-term infants. They consisted of 129 (20.0%) G6PD-deficient, 69 (10.7%) G6PD-intermediate, and 446 (69.3%) G6PD-normal neonates. The G6PD-deficient and G6PD-intermediate infants had higher mean TSB than their G6PD-normal counterparts at birth and throughout the first week of life (P < .001). Mean peak TSB levels were 14.1 (9.48), 10.2 (3.8), and 6.9 (3.3) mg/dL for G6PD-deficient, G6PD-intermediate, and G6PD-normal neonates, respectively. Peak TSB was attained on approximately day 4 in all 3 groups, and trends in TSB were similar. Mean hematocrits at birth were similar in the 3 G6PD groups. However, G6PD-deficient and -intermediate infants had higher declines in hematocrit, bilirubin levels, and need for phototherapy than G6PD-normal infants (P < .001). CONCLUSIONS: The G6PD-deficient and G6PD-intermediate neonates had a higher risk of neonatal hyperbilirubinemia and would therefore need greater monitoring in the first week of life, even without exposure to known icterogenic agents.

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2014-0654

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Owa, 1989, Neonatal Jaundice at Wesley Guild Hospital, Ilesa and Ife State Hospital, Ile-Ife., Niger J Paediatr, 16(1&2), 23
  2. Owa, 1987, Kernicterus in Nigerian infants., West Afr J Med, 6, 11
  3. Owa, 1991, Influence of glucose-6-phosphate dehydrogenase status on bilirubin and hematocrit in healthy Nigerian neonates., Niger Med Pract, 22, 47

Cited by

Sorted by citations

Metadata

Authors
Badejoko, B. O., Owa, J. A., Oseni, S. B. A., Badejoko, O., Fatusi, A. O., & Adejuyigbe, E. A.
Affiliations
  • Departments of Paediatrics,
  • Institute Of Perinatology Obstetrics And Gynaecology (AM)
  • Obafemi Awolowo University Teaching Hospitals Complex (NG)
Venue
Pediatrics
Published
2014-10-01
Volume
134
Issue
4
Pages
e1082-e1088
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2040975424
Cited by
24
References
15
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 5 · 2018: 3 · 2017: 2 · 2016: 3
FWCI
1.57
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
glucose-6-phosphate dehydrogenase deficiency, neonatal hyperbilirubinemia, total bilirubin, neonatal hematocrit, phototherapy, neonatal jaundice, term and near-term neonates
MeSH terms
Age Factors, Bilirubin, Female, Follow-Up Studies, Glucosephosphate Dehydrogenase, Glucosephosphate Dehydrogenase Deficiency, Hematocrit, Humans, Infant, Newborn, Male, Nigeria, Prospective Studies, Biomarkers, Hyperbilirubinemia, Neonatal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review